Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Income from Continuing Operations (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Income from Continuing Operations data on record, last reported at 5906000.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 77.88% year-over-year to 5906000.0; the TTM value through Sep 2025 reached 87124000.0, up 26.52%, while the annual FY2024 figure was 120843000.0, 21.61% up from the prior year.
  • Income from Continuing Operations reached 5906000.0 in Q3 2025 per FBIO's latest filing, up from 35851000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 5906000.0 in Q3 2025 and bottomed at 62330000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 37577473.68, with a median of 35851000.0 recorded in 2025.
  • Peak YoY movement for Income from Continuing Operations: tumbled 159.57% in 2021, then soared 78.69% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 62330000.0 in 2021, then rose by 7.92% to 57396000.0 in 2022, then surged by 49.5% to 28985000.0 in 2023, then rose by 18.79% to 23540000.0 in 2024, then soared by 74.91% to 5906000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 5906000.0 in Q3 2025, 35851000.0 in Q2 2025, and 21827000.0 in Q1 2025.